Deucravacitinib in moderate to severe plaque psoriasis: liver transaminase results from the phase 3 POETYK PSO program. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s116, 2023. DOI: 10.25251/skin.7.supp.116. Disponível em: https://skin.dermsquared.com/skin/article/view/1967. Acesso em: 17 may. 2025.